Drugs / Ringer's Lactate solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00694343 Comparator | Jun 2008 → Dec 2009 | hypotensive disorder | Fresenius Kabi | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ringer's Lactate solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00694343 ↗ |
| Route | Intravenous | “Patients received 500 ml of 6% HES (130/0.4)+500 ml of RL (HES group) or 1000 ml of RL (RL group) i.v. before SA.” PMID 24970272 ↗ Jun 2014 |